Search

Displaying results 4901 - 4910 of 10000 in total
  1. Drug

    SGI-1776

    go.drugbank.com/drugs/DB12494
    Investigational

    SGI-1776 has been used in trials studying the treatment of Prostate Cancer, Non-Hodgkins Lymphoma, and Relapsed/Refractory Leukemias.

  2. Drug

    Timbetasin

    go.drugbank.com/drugs/DB19119
    Investigational

    Timbetasin is under investigation in clinical trial NCT05555589 (Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2).

    Synonyms: 3,11,25,31,38-pentakis(de-n6-acetyl)-1,22,30,33-tetrakis(de-o3-phosphono)thymosin .beta.4(human), Thymosin .beta.(4), 3,11,25,31,38-pentakis(de-n6-acetyl)-1,22,30,33-tetrakis(de-o3-phosphono)-
  3. Drug

    PZ-128

    go.drugbank.com/drugs/DB11839
    Investigational

    PZ-128 has been used in trials studying the prevention and treatment of Heart Diseases, Coronary Disease, Arteriosclerosis, Vascular Diseases, and Myocardial Ischemia, among others.

  4. Drug

    Beroctocog alfa

    go.drugbank.com/drugs/DB14473
    ApprovedInvestigational

  5. Drug

    Lurbinectedin

    go.drugbank.com/drugs/DB12674
    ApprovedInvestigational

    Lurbinectedin is a DNA alkylating agent that has been investigated in the treatment of a variety of cancers, including mesothelioma, chronic lymphocytic leukemia (CLL), breast cancer, and small-cell lung cancer (SCLC). It is a derivative...

  6. Drug

    (R)-Propafenone

    go.drugbank.com/drugs/DB19162
    Investigational

    Propafenone, (r)- is under investigation in clinical trial NCT02710669 (New Formulations of Propafenone to Treat Atrial Fibrillation).

  7. Drug

    (S)-Propafenone

    go.drugbank.com/drugs/DB15410
    Investigational

    (S)-Propafenone is under investigation in clinical trial NCT02710669 (New Formulations of Propafenone to Treat Atrial Fibrillation).

  8. Drug

    Verubulin

    go.drugbank.com/drugs/DB05585
    Investigational

    Antineoplastic; a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps.

  9. Drug

    Ambasilide

    go.drugbank.com/drugs/DB19463
    Experimental

    The usage of the INN stem '-ilide' in the name indicates that Ambasilide is a sematilide derivative class III antiarrhythmic. Ambasilide has a monoisotopic molecular weight of 335.2 Da.

  10. Drug

    Bitipazone

    go.drugbank.com/drugs/DB19941
    Experimental

    The usage of the INN stem '-azone' in the name indicates that Bitipazone is a anti-inflammatory analgesic, phenylbutazone derivative. Bitipazone has a monoisotopic molecular weight of 454.27 Da.